Core Viewpoint - The company has not yet developed a robotics business, but its colloidal gold products, specifically the anti-HIV test kits, have been recognized by the WHO procurement list, indicating strong customer validation of its products [1] Company Developments - The company's subsidiary, Xi'an Tianlong, has a chikungunya virus RNA test kit (fluorescent PCR method) that has not yet applied for the National Medical Products Administration's medical device registration, and it is currently only available as a research reagent for customs and disease control applications [1] - The sales proportion of the chikungunya virus test kit is small and has not significantly impacted the company's consolidated revenue [1]

Group 1 - The company’s subsidiary, Xi'an Tianlong, has not applied for the National Medical Products Administration (NMPA) medical device registration certificate for its Chikungunya virus RNA detection kit (fluorescent PCR method) [2] - The detection kit is currently only available as a research reagent and is suitable for testing needs in customs and disease control scenarios [2] - The company will closely monitor market demand and will formulate product registration plans based on actual business needs and development strategies to actively seize related business opportunities [2]

Core Viewpoint - The company, Kehua Bio-engineering, has stated that its subsidiary, Xi'an Tianlong, has not applied for the National Medical Products Administration's medical device registration for its chikungunya virus RNA detection kit, which is currently only available as a research reagent for customs and disease control applications [1] Group 1 - The chikungunya virus RNA detection kit is based on fluorescent PCR technology [1] - The company is monitoring market demand closely and plans to develop a product registration strategy aligned with its business needs and development strategy [1] - The company aims to actively seize related business opportunities in the future [1]

Group 1 - The recent outbreak of Chikungunya fever has raised significant concern, with over 4,000 cases reported in Foshan, Guangdong, particularly in Shunde District, which accounts for 3,627 cases [1] - The disease is transmitted by Aedes mosquitoes and presents symptoms such as acute fever, severe joint pain, and rash, with higher risks for children, the elderly, and immunocompromised individuals [1] - Internationally, approximately one-third of the population in Réunion Island has been infected, and there is ongoing spread in Southeast Asian countries like India and Bangladesh, with cases also reported in France and Italy [1] Group 2 - Common detection methods for Chikungunya fever include serological testing, nucleic acid testing, and virus isolation, with specific timing for sample collection to ensure accurate results [2] - Companies like Kehua Bio-engineering have developed automated nucleic acid extraction instruments and testing kits for Chikungunya virus detection, which may expedite product approval and clinical data accumulation [2] - Renhe Pharmaceutical offers a range of mosquito repellent products, including floral water, mosquito patches, and electric mosquito repellent liquids, contributing to public health protection against mosquito-borne diseases [2]